What’s New

News Nov 18, 2024
Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial

September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality…

Publication Nov 6, 2024
Efficacy and Safety of Advanced Combination Treatment in Immune-Mediated Inflammatory Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Christopher Ma, Vipul Jairath, Virginia Salitano

Publication Aug 3, 2017
Evolving Concepts in Phases I and II Drug Development for Crohn’s Disease

Brian Feagan, Geert D’Haens, Niels Vande Casteele, Vipul Jairath

Publication Jul 29, 2017
Reliability of EUS Indices to Detect Inflammation in Ulcerative Colitis

Brian Feagan, Guangyong Zou, Vipul Jairath

Publication Jul 21, 2017
Histologic Scoring Indices for Evaluation of Disease Activity in Crohn’s Disease

Brian Feagan, Geert D’Haens, Vipul Jairath

Publication Jun 27, 2017
The Development of a Magnetic Resonance Imaging Index for Fistulising Crohn’s Disease

Brian Feagan, Geert D’Haens, Guangyong Zou, Vipul Jairath

Publication Jun 16, 2017
Pharmacokinetic Drug Evaluation of Budesonide in the Treatment of Crohn’s Disease

Brian Feagan, Vipul Jairath

Publication Jun 9, 2017
Development of a Core Outcome Set for Clinical Trials in Inflammatory Bowel Disease: Study Protocol for a Systematic Review of the Literature and Identification of a Core Outcome Set Using a Delphi Survey

Brian Feagan, Christopher Ma, Vipul Jairath